Thursday, 15 October 2026European Markets

PARETO BANK, EURONEXT, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - pareto bank (parb.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
pareto bank (parb.ol) kr53.10 7.34% 13.76%
euronext (enx.pa) €78.85 3.4% 10.56%
bank of ireland gp (birg.ir) €8.31 2.59% 12.05%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. pareto bank (parb.ol)

7.34% forward dividend yield and 13.76% return on equity

pareto bank asa provides various banking products and services in norway. the company accepts corporate deposits. it also offers corporate financing; receivables financing; residential and commercial financing for land and property; ship financing, including corporate and project financing; and other private or housing loans. pareto bank asa was incorporated in 2007 and is headquartered in oslo, norway.

earnings per share

as for profitability, pareto bank has a trailing twelve months eps of kr7.75.

pe ratio

pareto bank has a trailing twelve months price to earnings ratio of 6.85. meaning, the purchaser of the share is investing kr6.85 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.76%.

yearly top and bottom value

pareto bank's stock is valued at kr53.10 at 16:30 est, way under its 52-week high of kr59.50 and way above its 52-week low of kr46.05.

growth estimates quarters

the company's growth estimates for the current quarter is a negative 17.6% and positive 11.7% for the next.

more news about pareto bank.

2. euronext (enx.pa)

3.4% forward dividend yield and 10.56% return on equity

euronext n.v., together with its subsidiaries, operates securities and derivatives exchanges in continental europe, ireland, and norway. the company offers a range of exchange and corporate services, including security listings, cash and derivatives trading, and market data dissemination. it also provides listing venues and cash equities trading venues; and various marketplaces, including multilateral trading facilities for investors, broker-dealers, and other market participants to meet directly to buy and sell cash equities, fixed income securities, and exchange traded products. in addition, the company offers options contracts based on the blue-chip equities listed on euronext; commodity derivatives, such as milling wheat futures contracts; and post-trade services, as well as distributes and sells real-time, historic, and reference data to data vendors, and financial institutions and individual investors. further, it provides equity, debt, fund and etf listing, corporate and investor, cash trading, foreign exchange trading, derivatives trading, fixed income trading, and power trading services. additionally, the company offers technology solutions and services to exchanges, venue operators, and financial institutions; colocation, network and proximity services; and regulatory reporting services. the company was formerly known as euronext group n.v. and changed its name to euronext n.v. in may 2014. euronext n.v. was founded in 2000 and is headquartered in amsterdam, the netherlands.

earnings per share

as for profitability, euronext has a trailing twelve months eps of €4.95.

pe ratio

euronext has a trailing twelve months price to earnings ratio of 15.93. meaning, the purchaser of the share is investing €15.93 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.56%.

yearly top and bottom value

euronext's stock is valued at €78.85 at 16:30 est, higher than its 52-week high of €78.76.

more news about euronext.

3. bank of ireland gp (birg.ir)

2.59% forward dividend yield and 12.05% return on equity

bank of ireland group plc provides various banking and financial products and services. it provides current and savings accounts, and business deposits and accounts; personal, car, home improvement, graduate, motor finance, and student loans, as well as overdrafts; and business and farming loans, brexit loans, invoice finance, hire purchase, and leasing services. the company also offers international payments and credit cards; protection overview, mortgage protection, life cover, specified illness cover, income protection, protection for individuals, and protection for families; pensions and investments, foreign exchange, and treasury deposits and services; personal products; private banking services; and leveraged acquisition and property finance. in addition, it provides home, car, travel, and life insurance products. the company was founded in 1783 and is headquartered in dublin, ireland.

earnings per share

as for profitability, bank of ireland gp has a trailing twelve months eps of €1.27.

pe ratio

bank of ireland gp has a trailing twelve months price to earnings ratio of 6.54. meaning, the purchaser of the share is investing €6.54 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, bank of ireland gp's stock is considered to be oversold (<=20).

revenue growth

year-on-year quarterly revenue growth grew by 56.4%, now sitting on 3.79b for the twelve trailing months.

more news about bank of ireland gp.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com